International Patent: THIENOPYRIDONE COMPOUND AND USE THEREOF, AND ANTITUBERCULOSIS DRUG

GENEVA, July 31 -- GUANGZHOU NATIONAL LABORATORY filed a patent application (CN2026/073667) for “THIENOPYRIDONE COMPOUND AND USE THEREOF, AND ANTITUBERCULOSIS DRUG”. With publication no. WO/2026/158294, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 495/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....